Emilia Bulaevsky Zychlinsky
Chief Operating Officer at Exai Bio, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Patrick Arensdorf | M | - |
Exai Bio, Inc.
 Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Elizabeth Ann Hutt Pollard | F | 57 | 9 years | |
| Babak Alipanahi | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Hani Goodarzi | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Mike Pellini | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Shaun Rodriguez | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Seema Bhan | F | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brian E. Ward | M | 71 | 4 years | |
| Patrick Plewman | M | 58 | 1 years | |
| Lori F. Rafield | M | 69 | 8 years | |
| Christopher Lowe | M | 56 | - | |
| Alexander Johnson | M | - | 1 years | |
| Sarah Schiltz | F | - | 4 years | |
| John Curnutte | M | 72 | 1 years | |
| Leone Patterson | F | 61 | 1 years | |
| Andrew Galligan | M | 67 | 5 years | |
| James Sulat | M | 73 | 1 years | |
| David J. Foster | M | 66 | 1 years | |
| Louis C. Bock | M | 59 | 1 years | |
| Charles W. Patrick | M | 69 | 5 years | |
| Adeoye Olukotun | M | 79 | 2 years | |
| Paul Manners | M | - | - | |
| Jonathan Ruais | M | 47 | 1 years | |
| William Harrison Hammond | M | - | 1 years | |
| Mika Newton | M | - | - | |
| Robert Michael Richey | M | 71 | 3 years | |
| Jean-Frédéric Viret | M | 58 | 2 years | |
| E. Ralf Schoenbrunner | M | - | - | |
| Kenneth Charles Fang | M | 61 | - | |
| John Sperzel | M | 60 | - | |
| Robert J. Schott | M | - | - | |
| David W. Nikka | M | 69 | 2 years | |
| Robert L. Wolfert | M | 70 | 1 years | |
| Alexander Johnson | M | 50 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 34 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Emilia Bulaevsky Zychlinsky
- Personal Network
